We’ll be taking a break in May, June, and July while our host is on maternity leave. See you again in August!   This week on Pharm5: Vowst (SER-109) for recurrent C Diff Trikafta for CF in 2+ years Mounjaro for weight loss in diabetes Qalsody accelerated approval for ALS J&J talc baby powder settlement   Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD   References: FDA approves first orally administered fecal microbiota product for the prevention of recurrence of Clostridioides difficile infection. U.S. Food and Drug Administration ..read more

This week on Pharm5: PREP act extended to December 2024 Doxy-PEP for MSM Medicare expands CGM coverage COVID vaccine changes DEA Drug Take Back Day   Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD   References: Fact sheet: HHS announces intent to amend the declaration under the PREP Act for medical countermeasures against COVID-19. HHS.gov. https://bit.ly/3osEGZ4. Published April 14, 2023. Accessed April 20, 2023. HHS extends PREP act for certain pharmacist and technician services. ASHP. https://bit.ly/3ovmq19. Accessed April 20, 2023. Luetk ..read more

This week on Pharm5: Mifepristone’s FDA approval up in the air Statins for primary prevention in PLWH Xylazine sedative found in illicit fentanyl Death by H3N8 avian flu Phase II Match Day In in honor of National Minority Health Month, this week's episode was fully written, developed, and recorded by members of the Student National Pharmaceutical Association (SNPhA) at the HSC College of Pharmacy. Thank you to SNPhA members Hillary Matthews, Alyssa Ching, Jalyn Vance, Brizeek Martin, Lauren Robertson, ChiChi Opara, Jared Mitchell, Jasmine Hill, and Alexis Zamora for your contributions!  ..read more

This week on Pharm5: OTC Narcan (naloxone) Higher dose Rybelsus (semaglutide) iPLEDGE REMS in discussion WHO COVID-19 guidance for healthy kids Pradaxa (dabigatran) recall   Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD   References: FDA approves first over-the-counter naloxone nasal spray. U.S. Food and Drug Administration. http://bit.ly/42O0I8a. Accessed March 29, 2023. Hoffman J. Over-the-counter Narcan could save more lives. but price and stigma are obstacles. The New York Times. http://bit.ly/3lWSrhF. Published March 28, 2023. Accessed ..read more

This week on Pharm5 Humira biosimilars Vyvanse, Symbicort, and more losing patents this year Rezafungin approval Senate Committee meets on drug shortages COVID-19 declassified   Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD   References: Sandoz receives US FDA approval for biosimilar Hyrimoz® (Adalimumab-adaz) high-concentration formulation. Novartis. http://bit.ly/3lBJ1rK. Published March 21, 2023. Accessed March 23, 2023. Humira [package insert].North Chicago, IL: AbbVie Inc. Accessed March 23, 2023. Stonehill M. Humira exclusivity expire ..read more

This week on Pharm5: Novo Nordisk insulin price cuts Akorn Pharma closing, potential drug shortages Zavzpret (zavegepant) migraine nasal spray Daybue (trofinetide) for Rett Syndrome 2023 Match Results Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024. Novo Nordisk. http://bit.ly/42hziHz. Accessed March 16, 2023. Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month ..read more

This week on Pharm5: Voluntary eyedrop recalls Bempedoic acid lowers MACE risk LDL <70 vs. high-intensity statin Walgreens halting mifepristone COVID-19 vaccines in pregnancy Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: O'Mary L. Bacterial outbreak linked to EzriCare eyedrops: CDC. Medscape. http://bit.ly/3l3tOz9. Published February 1, 2023. Accessed February 2, 2023. Update: Multistate Cluster of VIM- and GES-producing Carbapenem resistant Pseudomonas aeruginosa associated with Artificial Tears. https://bit.ly/3DDHrey. Published Ja ..read more

This week on Pharm5: Detailing Eli Lilly’s insulin pricing RSV vaccines on the horizon XDR shigellosis health advisory OTC Flu+COVID test ASHP Match Rankings due 11:59 PM Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month. Eli Lilly and Company. http://bit.ly/3ZQXVcf.  Published March 1, 2023. Accessed March 2, 2023. Christensen J, Klein B. Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetes. CNN. http://bit.ly/3IHm ..read more

This week on Pharm5: Ivermectin fails against COVID-19 Cabenuva noninferior to Biktarvy Syfovre for geographic atrophy Aspirin for pre-eclampsia prevention TRUNCATE-TB results could shorten TB treatment Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Naggie S, Boulware DR, Lindsell CJ, et al. Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with covid-19. JAMA. February 2023. doi:10.1001/jama.2023.1650. Efficacy: Cabenuva (cabotegravir; Rilpivirine). Efficacy: Every 2 Month | CABENUVA Off ..read more

This week on Pharm5: Narcan possibly OTC soon Dexcom G7 now available PBM Transparency Act hearing Rocuronium shortage Phase I Rankings now open Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Hoffman J. Narcan is safe to sell over the counter, advisers to the F.D.A. conclude. The New York Times. http://bit.ly/3S2btPf. Published February 15, 2023. Accessed February 16, 2023. Person, Bhanvi Satija PJ. U.S. FDA panel backs OTC opioid overdose drug, proposes label changes. Reuters. http://bit.ly/3xrx0r5. Published February 16, 2023. Accessed ..read more